EUVIMEDEUVIMED entdecken
Open Access

Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier

Yunting Zhu iD, Maree J Webster, Gerardo Mendez Victoriano, Frank A Middleton, Paul T Massa, Cynthia Shannon Weickert

Schizophrenia Bulletin · 2025

DOI: 10.1093/schbul/sbae184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2025. Verfasst von Yunting Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY 13210, United States. Hauptthemen laut MEDLINE: Schizophrenia, Blood-Brain Barrier, Bipolar Disorder, Neuroinflammatory Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The NSW Ministry of Health, Office of Health and Medical Research, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Angiogenesis triggered by inflammation increases BBB permeability and facilitates macrophage transmigration. In the midbrain, we have discovered molecular alterations related to the blood-brain barrier (BBB), including endothelial cell changes associated with macrophage diapedesis, in neuroinflammatory schizophrenia and bipolar disorder, but changes in angiogenesis are yet to be reported. Hypothesis: We expected to discover molecular evidence of altered angiogenesis in the midbrain in individuals with schizophrenia and bipolar disorder compared to controls, with these changes more evident in “high” inflammation schizophrenia as compared to “low” inflammation. Study Design In a case-control post-mortem cohort including schizophrenia (n = 35), bipolar disorder (n = 35), and controls (n = 33), we measured mRNA (RT-PCR) and protein (multiplex immunoassays) and performed immunohistochemistry to determine levels and anatomical distribution of angiogenesis-related molecules in the ventral midbrain. Study Results We found large changes in angiogenesis factors in bipolar disorder high inflammatory subgroup (increased angiopoietin-2 and SERPINE1 mRNAs, but decreased angiopoietin-1, angiopoietin-2, and TEK receptor proteins). In schizophrenia high inflammatory subgroup, we found a robust increase in SERPINE1 mRNA and protein levels. However, we found no significant changes in angiopoietins in schizophrenia. We found that VEGFA mRNA level was increased in high inflammation schizophrenia, but only reached statistical significance compared to one low inflammatory subgroup. Conclusions Thus, angiogenesis signaling pathways appeared to be involved in the BBB alterations when inflammation is also present in the midbrain of schizophrenia and bipolar disorder, with increased levels of SERPINE1 in schizophrenia high inflammatory subgroup and with a putative suppression of angiopoietin signaling in bipolar disorder high inflammatory subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaBlood-Brain BarrierBipolar DisorderNeuroinflammatory DiseasesMesencephalonNeovascularization, PathologicInflammationHumansMaleFemaleMiddle AgedCase-Control StudiesAdultAngiopoietin-1AgedAngiopoietin-2Plasminogen Activator Inhibitor 1Vascular Endothelial Growth Factor AAngiogenesis

Stichwörter der Autor:innen

angiogenesisangiopoietinbipolar disorderblood-brain barrierinflammationschizophrenia

Substanzen

Angiopoietin-1Angiopoietin-2SERPINE1 protein, humanPlasminogen Activator Inhibitor 1Vascular Endothelial Growth Factor AANGPT2 protein, humanANGPT1 protein, human

Autor:innen und Institutionen

  • Department of Neuroscience and Physiology, Upstate Medical University, Syracuse, NY 13210, United States.
  • Stanley Medical Research Institute, 9800 Medical Center Drive, Rockville, MD, United States.
  • Schizophrenia Research Laboratory, Neuroscience Research Australia, Randwick, NSW 2031, Australia.
  • School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney NSW 2052, Australia.
  • Department of Neurology, Upstate Medical University, Syracuse, NY 13210, United States.
  • Department of Microbiology and Immunology, Upstate Medical University, Syracuse, NY 13210, United States.

ORCID-Profile: Yunting Zhu

Förderung

  • The NSW Ministry of Health, Office of Health and Medical Research
  • National Health and Medical Research Council

Zitieren

APA

Zhu, Y., Webster, M. J., Mendez Victoriano, G., Middleton, F. A., Massa, P. T., & Weickert, C. S. (2025). Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae184

Vancouver

Zhu Y, Webster MJ, Mendez Victoriano G, Middleton FA, Massa PT, Weickert CS. Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier. Schizophrenia Bulletin. 2025. doi:10.1093/schbul/sbae184

BibTeX
@article{Zhu2025,
  author = {Zhu, Yunting and Webster, Maree J and Mendez Victoriano, Gerardo and Middleton, Frank A and Massa, Paul T and Weickert, Cynthia Shannon},
  title = {Molecular Evidence for Altered Angiogenesis in Neuroinflammation-Associated Schizophrenia and Bipolar Disorder Implicate an Abnormal Midbrain Blood-Brain Barrier},
  journal = {Schizophrenia Bulletin},
  year = {2025},
  doi = {10.1093/schbul/sbae184}
}
Kostenlos starten →